Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide-1 Receptor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT02055014
What this trial is testing

Randomisation to Endobarrier Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity)

Who this might be right for
Type 2 DiabetesObesityDiabesity
Sandwell & West Birmingham Hospitals NHS Trust 72
Large-scale testing (Phase 3)Looking for participantsNCT06387199
What this trial is testing

Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide

Who this might be right for
Type 1 DiabetesDiabetes Mellitus
McGill University Health Centre/Research Institute of the McGill University Health Centre 26
Not applicableLooking for participantsNCT06839248
What this trial is testing

Effect of Fasting Recommendations Among Patients Using GLP-1 Receptor Agonists

Who this might be right for
Residual Gastric ContentsPulmonary Aspiration of Gastric Contents
St Vincent's Hospital Melbourne 154
Testing effectiveness (Phase 2)Looking for participantsNCT07467447
What this trial is testing

Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight

Who this might be right for
Obesity
Hudson Biotech 300
Testing effectiveness (Phase 2)Looking for participantsNCT07202247
What this trial is testing

Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial

Who this might be right for
Prostate CarcinomaRecurrent Prostate Carcinoma
City of Hope Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT06481085
What this trial is testing

To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 324
Testing effectiveness (Phase 2)UnknownNCT04535960
What this trial is testing

Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial

Who this might be right for
Type 2 Diabetes Mellitus
University Health Network, Toronto 36
Not applicableNot Yet RecruitingNCT07701460
What this trial is testing

Assessing Follow up Trajectories in Eating, Routines, and Weight After GLP-1

Who this might be right for
Weight Maintenance
Tufts University 200
Not applicableLooking for participantsNCT07779343
What this trial is testing

OBESIAL: A Prospective Interventional Real-world Study of a Multidisciplinary Obesity Management Programme

Who this might be right for
Obesity Difficult Airway Airway ManagementObesity Adult OnsetObesity and Cardiovascular Risk+1 more
University of Health Sciences, Algeria 300
Not applicableStudy completedNCT01281228
What this trial is testing

The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 2Obesity
Amsterdam UMC, location VUmc 48
Large-scale testing (Phase 3)Study completedNCT05205928
What this trial is testing

Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Care

Who this might be right for
Type 1 DiabetesDiabetes Mellitus, Type 1
McGill University Health Centre/Research Institute of the McGill University Health Centre 28
Post-approval studies (Phase 4)Active Not RecruitingNCT06803888
What this trial is testing

Bariatric Surgery vs. Semaglutide vs. Tirzepatide

Who this might be right for
Obesity and Obesity-related Medical Conditions
Ali Aminian 140
Post-approval studies (Phase 4)UnknownNCT04029272
What this trial is testing

Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients

Who this might be right for
Polycystic Ovary Syndrome
Peking Union Medical College Hospital 80
Very early researchLooking for participantsNCT06751589
What this trial is testing

A Weight Loss Intervention in People With Endometrial Cancer

Who this might be right for
Endometrial Cancer
Memorial Sloan Kettering Cancer Center 36
Post-approval studies (Phase 4)Looking for participantsNCT07163650
What this trial is testing

Evaluating Anti-Obesity Medications 6 Months After Metabolic Surgery

Who this might be right for
ObesityWeight LossMetabolic Surgery
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 60
Not applicableStudy completedNCT06500143
What this trial is testing

Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery

Who this might be right for
Gastric Retention
Ciusss de L'Est de l'Île de Montréal 94
Not applicableStudy completedNCT03246451
What this trial is testing

The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin in Patients With T2D

Who this might be right for
Glucose Metabolism Disorders
University Hospital, Gentofte, Copenhagen 15
Not applicableLooking for participantsNCT07224880
What this trial is testing

Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists

Who this might be right for
glp1 AgonistGene ExpressionSkin Laxity
Cytrellis Biosystems, Inc. 10
Not applicableActive Not RecruitingNCT05333003
What this trial is testing

Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity

Who this might be right for
Schizophrenia Spectrum Disorders
Centre for Addiction and Mental Health 92
Early research (Phase 1)Not Yet RecruitingNCT07550634
What this trial is testing

Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic Impairment

Who this might be right for
Hepatic Impairment (Mild and Moderate, Child-Pugh Class A and B)Hepatic Insufficiency (MeSH ID: D048550)
MindRank AI Ltd 32
Next Page